A New Preview of Antibiotic-resistant Spectrum in Community-acquired Pneumonia: A Cross-Sectional Study from Iraq

Marwan Majeed Ibrahim1, Yusur Muhammad Said Thabit Al-Rawi2

  • 1Department of Medicine, College of Medicine, Mustansiriyah University, Baghdad, Iraq.

Abstract

Insights

Antimicrobial resistance in community-acquired pneumonia (CAP) is a serious concern in Iraq. This study found alarmingly high resistance rates, including pan-resistant strains, necessitating urgent antibiotic stewardship programs.

Area of Science:

  • Medical Microbiology
  • Infectious Diseases
  • Public Health

Background:

  • Community-acquired pneumonia (CAP) is a major global health challenge, exacerbated by rising antimicrobial resistance (AMR).
  • Understanding local resistance patterns is crucial for effective treatment of CAP, particularly in regions with limited data like Iraq.

Purpose of the Study:

  • To determine the prevalence of antibiotic resistance in bacterial pathogens causing CAP in Iraq.
  • To identify common CAP pathogens and their susceptibility profiles to various antibacterial agents.

Main Methods:

  • A cross-sectional study involving 122 CAP patients at Al-Yarmouk Teaching Hospital, Baghdad.
  • Sputum samples were analyzed using microscopy, culture, and the VITEK® 2 system for bacterial identification and antibiotic susceptibility testing.

Main Results:

  • 44% of patients had positive bacterial cultures, with common pathogens including *S. pneumoniae*, *S. sanguinis*, *S. aureus*, and *P. aeruginosa*.
  • *S. pneumoniae* and *S. sanguinis* exhibited 100% resistance to azithromycin, clindamycin, and ciprofloxacin.
  • Alarmingly high resistance was observed in *S. aureus* and *Acinetobacter baumannii*, including pan-resistant strains.

Conclusions:

  • This study highlights critical levels of antibiotic resistance among CAP pathogens in Iraq.
  • Urgent implementation of antibiotic stewardship programs and regulation of antibiotic sales is essential to combat rising AMR in Iraq.

Related Concept Videos

Antibiotic Selection00:57

Antibiotic Selection

Overview
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...